SELB - Selecta Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Selecta Biosciences's activity chart (see below) currently has 46 price targets and 48 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 18-Aug-2023. First documented stock forecast 18-Jul-2016.

Best performing analysts who are covering SELB - Selecta Biosciences:

Eliana Merle

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Nov-2021

$4

$4 (0.00%)

$5

3 years 1 months 14 days ago
(18-Aug-2023)

0/7 (0%)

$4 (0.00%)

Buy Since 10-Mar-2022

3 years 1 months 14 days ago
(18-Aug-2023)

0/1 (0%)

$8 (0.00%)

Buy Since 12-Jun-2020

$5

$5 (0.00%)

3 years 1 months 14 days ago
(18-Aug-2023)

0/5 (0%)

$5 (0.00%)

Buy Since 18-Jul-2016

3 years 8 months 1 days ago
(31-Jan-2023)

0/4 (0%)

$40 (0.00%)

Hold

$9

$7.9 (718.18%)

4 years 10 months 6 days ago
(26-Nov-2021)

0/1 (0%)

$6.1 (210.34%)

Show more analysts

Please expand the browser size to see the chart

Which analyst most recently updated their price target on SELB (Selecta Biosciences)?

Gil Blum

Which analyst has the most public recommendations on SELB (Selecta Biosciences)?

Gil Blum works at NEEDHAM and has 43 price targets and 29 ratings on SELB

Which analyst is the currently most bullish on SELB (Selecta Biosciences)?

Jeffrey Hung with the highest potential upside of $29

Which analyst is the currently most reserved on SELB (Selecta Biosciences)?

Difei Yang with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?